Resources

Treatment of postprandial hyperglycemia with acarbose did not prevent or delay disease progression in patients with early type 2 diabetes.

If French scientists are to be believed being obese is linked to a decline in a person’s cognitive function.

Results of a study provide more evidence for an association between use of second-generation antipsychotic drugs — in this case olanzapine, quetiapine, and risperidone — and the onset of diabetes.

Too little sleep may explain soaring levels of obesity in children, according to a scientist from Bristol University.

For every four adults in the world who are malnourished five more are overweight, 30 percent of them clinically obese, according to the World Health Organization.

At a time when another TZD, rosiglitizone is showing promise in preventing diabetes, this new review calls into the question the health benefits versus risks of Actos, an oral medicine widely prescribed for diabetes throughout the United States, Canada, Europe and Asia.

Drinking 6 ounces of pomegranate juice daily may protect diabetics from developing heart disease, according to a new study.

According to the results of a new study, DHEA, a widely used antiaging supplement has no effect on aging markers such as muscle strength, peak endurance, muscle mass, fat mass and glucose tolerance in elderly men and women.

Last time Sheri Colberg, Ph.D., FACSM had some great insight as to why patients do not lose weight even though they exercise. This week she helps you give your patients tips on how to Get moving with extra steps.

The FDA announced today the approval of Januvia (sitagliptin phosphate) Tablets, the first diabetes treatment approved in a new class of drugs known as DDP-4 inhibitors that enhances the body’s own ability to lower elevated blood sugar.